Anticholinergic Cognitive Burden as a Predictive Factor for In-hospital Mortality in Older Patients in Korea

다국어 초록 (Multilingual Abstract)

Background: With the increasing prevalence of chronic disease due to aging, many older adults experience multimorbidity and polypharmacy. Medications with anticholinergic properties are particularly associated with adverse cognitive outcomes, including functional decline and mortality. We assessed the clinical impact of anticholinergic cognitive burden (ACB) on clinical outcomes of older patients acutely admitted to a single, hospitalist-operated medical unit of a tertiary hospital in Korea. Methods: This retrospective study reviewed electronic medical records of 318 patients aged 65 years or older admitted to the hospitalist-operated medical unit through the emergency department of Seoul National University Hospital. The analyzed clinical outcomes were the length of hospital stay, in-hospital mortality, unplanned intensive care unit admission, and unexpected readmission within 30 days. Results: The clinical outcomes did not differ between patients who took five or more drugs and those who did not. Patients with an ACB score of 3 or higher had a higher in-hospital mortality rate and longer hospital stay than those who did not. After adjusting for confounding factors, an ACB score of 3 or higher was an independent predictive factor for in-hospital mortality (odds ratio=3.09; 95% confidence interval, 1.18–8.06). Conclusion: ACB rather than the number of medications was associated with in-hospital mortality in acutely ill older patients. Further analytic and interventional studies are required to assess potentially inappropriate medication use and ACB in older inpatients.

참고문헌 (Reference)

1 정희원, "다중이환의 개념과 노인의학적 의의" 대한노인병학회 18 (18): 65-71, 2014

2 Han L, "Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients" 161 : 1099-1105, 2001

3 Kidd AC, "The relationship between total anticholinergic burden(ACB)and early in-patient hospital mortality and length of stay in the oldest old aged 90 years and over admitted with an acute illness" 59 : 155-161, 2014

4 Feinberg M, "The problems of anticholinergic adverse effects in older patients" 3 : 335-348, 1993

5 Rochon PA, "The prescribing cascade revisited" 389 : 1778-1780, 2017

6 van den Boogaard M, "The impact of delirium on the prediction of in-hospital mortality in intensive care patients" 14 : R146-, 2010

7 Taro Kojima, "The Need for Actions Against Polypharmacy in Older People With Frailty" 대한노인병학회 22 (22): 111-116, 2018

8 Duran CE, "Systematic review of anticholinergic risk scales in older adults" 69 : 1485-1496, 2013

9 Gallagher P, "STOPP(Screening Tool of Older Persons' potentially inappropriate Prescriptions) : application to acutely ill elderly patients and comparison with Beers' criteria" 37 : 673-679, 2008

10 Scott IA, "Reducing inappropriate polypharmacy : the process of deprescribing" 175 : 827-834, 2015

11 Mizokami F, "Polypharmacy with common diseases in hospitalized elderly patients" 10 : 123-128, 2012

12 Corsonello A, "Polypharmacy in elderly patients at discharge from the acute care hospital" 3 : 197-203, 2007

13 Hajjar ER, "Polypharmacy in elderly patients" 5 : 345-351, 2007

14 Rochon PA, "Optimising drug treatment for elderly people : the prescribing cascade" 315 : 1096-1099, 1997

15 Samaras N, "Older patients in the emergency department : a review" 56 : 261-269, 2010

16 Zimmerman KM, "Increasing anticholinergic burden and delirium in palliative care inpatients" 28 : 335-341, 2014

17 Hein C, "Impact of polypharmacy on occurrence of delirium in elderly emergency patients" 15 : 850-, 2014

18 Boustani M, "Impact of anticholinergics on the aging brain : a review and practical application" 4 : 311-320, 2008

19 Il-Young Jang, "Geriatrics Fact Sheet in Korea 2018 From National Statistics" 대한노인병학회 23 (23): 50-53, 2019

20 Hee-Won Jung, "Geriatric Medicine, an Underrecognized Solution of Precision Medicine for Older Adults in Korea" 대한노인병학회 22 (22): 157-158, 2018

21 Dauphinot V, "Exposure to anticholinergic and sedative drugs, risk of falls, and mortality: an elderly inpatient, multicenter cohort" 34 : 565-570, 2014

22 van Hemert AM, "Excess mortality in general hospital patients with delirium : a 5-year follow-up of 519 patients seen in psychiatric consultation" 38 : 339-346, 1994

23 Moo-Young Kim, "Development of a Consensus List of Potentially Inappropriate Medications for Korean Older Adults" 대한노인병학회 22 (22): 121-129, 2018

24 Salahudeen MS, "Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people" 63 : 85-90, 2015

25 Campbell N, "C46 : The 2012 update to the anticholinergic cognitive burden scale" 61 (61): S142-S143, 2013

26 Fox C, "Anticholinergic medication use and cognitive impairment in the older population : the medical research council cognitive function and ageing study" 59 : 1477-1483, 2011

27 By the 2019 American Geriatrics Society Beers Criteria Update Expert Panel, "American Geriatrics Society 2019 Updated AGS Beers Criteria for Potentially Inappropriate Medication use in older adults" 67 : 674-694, 2019

28 Marengoni A, "Aging with multimorbidity : a systematic review of the literature" 10 : 430-439, 2011

29 Blokland A, "Acetylcholine: a neurotransmitter for learning and memory?" 21 : 285-300, 1995

30 Gill SS, "A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs" 165 : 808-813, 2005